The Bangalore District Chemists & Druggists Association (BDCDA) has welcomed the CDSCO’s new guidance on safe disposal of expired and unused medicines but flagged several practical challenges in its implementation, especially from a retailer’s perspective.

Key highlights

Retailers seek clarity on returns and timelines

• BDCDA raised concerns over the lack of policy on strip-cutting and reimbursement of partially sold strips.

• Requested CDSCO to reconsider the 30-day return timeline and align it with industry standards of 90–150 days.

• Noted batch number mismatches due to fragmented supply chains as a major hurdle.

Appreciation for public health intent

• BDCDA praised the guidance for focusing on consumer safety and environmental protection.

• Backed drug take-back programs and flushing of high-risk medicines to prevent misuse.

Suggested operational workflow for expired drug returns

• Proposed that retailers raise return invoices to wholesalers, with Biomedical Waste Agencies handling collections.

• Recommended credit note system between wholesalers and manufacturers for reconciliation.

• Called for special mechanisms to handle returns in PCD pharma franchises and generic trade with high margins.

Need for clear SOP on surgical disposables

• BDCDA asked for guidelines on the disposal of surgical items like gloves and syringes.

• Stressed the need for waste segregation protocols and licensing clarity.

Push for digital tracking and single-window systems

• Advocated for a national batch registry, brand coding system, and blockchain-based traceability.

• Proposed interconnected platforms for real-time expiry and return data sharing across the supply chain.

BDCDA has shown readiness to support CDSCO’s efforts toward structured pharmaceutical waste management but urged the regulator to enable a unified, digitized, and industry-aligned system. The association reaffirmed its commitment to medicine safety, traceability, and environmental sustainability.